Clinical Trials
Medidata and Thermo Fisher Scientific’s PPD Clinical Research Business Collaborate to Accelerate Clinical Trials Innovation
Agreement spans wide range of Medidata’s solutions to enhance clinical trial efficiency 28/02/2024 — NEW YORK — (BUSINESS WIRE) Medidata, a Dassault Systèmes company and leading provider of clinical trial […]
Pulmonx Announces Treatment of the First Patient with the AeriSeal® System in CONVERT II Pivotal Trial
AeriSeal System Shows Promise in Limiting Collateral Ventilation, Potentially Enabling a Greater Number of Severe COPD/Emphysema Patients to Benefit from Treatment with Zephyr® Valves, a Minimally Invasive Treatment Option 26/02/2024 […]
Medidata and Sanofi Vaccines Extend Collaboration to Improve Patient Centricity and Trial Efficiency
Collaboration will harness Medidata Electronic Clinical Outcome Assessment (eCOA) for remote patient engagement and real-time data capture 06/02/2024 — NEW YORK — (BUSINESS WIRE) Medidata, a Dassault Systèmes company and […]
Medidata Secures Top Honors in Everest Group’s Decentralized Clinical Trial Platforms PEAK Matrix® Assessment
Medidata named a market Leader and the only provider to receive a “Star Performer” designation year over year 10/01/2024 — NEW YORK — (BUSINESS WIRE) Medidata, a Dassault Systèmes company […]
Empatica Announces Plans for Landmark Clinical Study to Develop an AI-Based Seizure Forecast Based on Wearable Real-World Data
First-of-its-Kind Study will Use FDA-Cleared Wearable Technology to Better Understand and Predict Seizures 30/11/2023 — BOSTON — (BUSINESS WIRE) Empatica, a digital health and AI company developing medical-grade wearables and […]
Exciting Progress | Gritgen Therapeutics Completed Patients Enrollment in China’s First Gene Therapy Investigator-Initiated Trial for Hemophilia A and also Achieved the First Patient Dosed in China Phase I Trial in Patients with Severe Hemophilia A
16/11/2023 — SUZHOU, China — (BUSINESS WIRE) Gritgen Therapeutics Co., Ltd. (Gritgen), a biotechnology company focused on identifying and developing innovative gene therapy products to achieve “Great Science for Human […]
SubjectWell Acquires PatientCentra
Acquisition unlocks ability to recruit for global trials, as well as rare disease and oncology indications 02/11/2023 — AUSTIN, Texas — (BUSINESS WIRE) SubjectWell, the patient access marketplace that connects […]
Dexcom Solidifies Global Leadership in Continuous Glucose Monitoring With New Clinical Data Presented at EASD
02/10/2023 — SAN DIEGO — (BUSINESS WIRE) DexCom, Inc. (NASDAQ: DXCM), the global leader in real-time continuous glucose monitoring for people with diabetes, announced today new clinical study outcomes that […]
Tasso Receives CE Mark Certification for Tasso+™, Latest Generation Whole Blood Collection Lancet Device
Designation expands the availability of Tasso’s patient-centric blood collection solution for decentralized clinical trials, home diagnostic testing, wellness and anti-doping uses to the European Union 19/09/2023 — SEATTLE — (BUSINESS […]
Memgen Announces New Clinical Data on MEM-288 in Advanced/Metastatic NSCLC at ASCO 2023 Annual Meeting
06/06/2023 — TAMPA, Fla. — (BUSINESS WIRE) Memgen, Inc., a clinical-stage biotechnology company today announced updated clinical data from its first-in-human study of MEM-288, an oncolytic viral therapy, in patients […]
Airway Therapeutics Completes Enrollment in Phase 1b Trial of Zelpultide Alfa (AT-100) for Very Preterm Infants at Risk for Bronchopulmonary Dysplasia
05/06/2023 — ATLANTA — (BUSINESS WIRE) Airway Therapeutics, Inc., a biopharmaceutical company developing a new class of biologics to break the cycle of injury and inflammation for patients with respiratory […]
Airway Therapeutics Completes Dose Escalation in Phase 1b Trial of Zelpultide Alfa (AT-100) for Very Preterm Infants at Risk for Bronchopulmonary Dysplasia
11/04/2023 — ATLANTA — (BUSINESS WIRE) Airway Therapeutics, Inc., a biopharmaceutical company developing a new class of biologics to break the cycle of injury and inflammation for patients with respiratory […]
Allucent Expands Use of Medidata Clinical Cloud to Accelerate New Drug Development for Unmet Patient Needs
07/03/2023 — NEW YORK — (BUSINESS WIRE) Medidata, a Dassault Systèmes company, today announced that Allucent, a contract research organization (CRO) bringing innovation to biopharma companies, is expanding the global […]
Medidata Drives Diversity in Clinical Trials, Passing 30,000 Studies and 9 Million Participants
Unprecedented industry milestones achieved with continuous innovation supporting the digital transformation of life sciences 02/03/2023 — NEW YORK — (BUSINESS WIRE) Known for its ground-breaking technological innovations in clinical trials, […]
Dexcom Showcases Accuracy, Simplicity and Connectivity of Its CGM Portfolio at ATTD Conference as Access to CGM Expands Globally
22/02/2023 — SAN DIEGO — (BUSINESS WIRE) DexCom, Inc. (NASDAQ: DXCM), the global leader in real-time continuous glucose monitoring (CGM) for people with diabetes, will showcase the strength of its […]
Oxular Limited Announces Acceptance of IND for Suprachoroidal OXU-001 for the Treatment of Diabetic Macular Edema
OXU-001 represents potential best-in-class treatment for DME with just one, targeted administration per year Initiation of OXEYE Phase 2 clinical trial of OXU-001 in DME patients on-track for first quarter […]
Partnership to Fight Infectious Disease Launches European Chapter
Antimicrobial Resistance is Set to Become the Next Public Health Emergency 15/12/2022 — BRUSSELS — (BUSINESS WIRE) Infections due to antimicrobial resistance (AMR) are a significant threat to modern healthcare […]
Agendia Announces First Patient Enrolled in Prospective LESS Clinical Study, Sponsored by Unicancer, to De-escalate Endocrine Therapy in Women with Early Breast Cancer
The LESS study will evaluate reduced endocrine therapy for HR+/HER2- patients with MammaPrint® Ultra Low tumors to improve quality of life without compromising outcomes Study strengthens Agendia’s growing global footprint […]
Medidata Launches Rave Companion, the First Scalable Solution for Automating EHR Data Entry into Rave EDC
Rave Companion Modernizes the EDC User Experience, Saving Thousands of Potential Errors for Clinical Trial Sites and Data Managers Rave Companion increases data quality and can lower monitoring costs by […]
Seagen Names David R. Epstein as Chief Executive Officer and Director
-Roger Dansey, M.D., Appointed President, Research and Development – 10/11/2022 — BOTHELL, Wash. — (BUSINESS WIRE) Seagen Inc. (Nasdaq: SGEN) today announced that its Board of Directors has appointed David […]
Oxular Limited Appoints Industry Veteran James Jogerst as Chief Business Officer
07/11/2022 — OXFORD, England — (BUSINESS WIRE) Oxular Limited, a clinical-stage retinal therapeutics company developing long-lasting targeted treatments for retinal disorders to improve patients’ vision, today announced the appointment of […]
Boehringer Ingelheim Extends the Use of Medidata Rave for Electronic Data Capture in Clinical Trials
Collaboration Includes Industry-Leading Technologies and Decentralized Clinical Trial Capabilities to Increase Study Efficiency and Patient Engagement 27/10/2022 — NEW YORK — (BUSINESS WIRE) Medidata, a Dassault Systèmes company, and Boehringer […]
New Medidata Technology Helps Sponsors and CROs Improve Diversity and Inclusion in Clinical Trials
Intelligent Trials Diversity Module Addresses Critical Need to Increase Study Access and Engagement 13/10/2022 — NEW YORK — (BUSINESS WIRE) Medidata, a Dassault Systèmes company, has launched the Intelligent Trials […]
NICE Publishes Final Appraisal Document Recommending the Use of Adtralza® (tralokinumab) for Adult Patients With Moderate-to-Severe Atopic Dermatitis
NICE Publishes Final Appraisal Document Recommending the Use of Adtralza® (tralokinumab) for Adult Patients With Moderate-to-Severe Atopic Dermatitis The National Institute for Health and Care Excellence (NICE) has published a […]
Agendia Presents Data from the FLEX Real World Evidence Trial in Seven Posters at ASCO 2022, Showcasing the Power of Its 30,000-Patient Breast Cancer Genome Project
Data show MammaPrint® is the first and most comprehensive FDA-cleared test for early breast cancer resulting in the ability to identify women who may be over- or under-treated if treatment […]
Agendia Presents Data at ASCO 2022 Pointing to New Signature ImPrint Immunotherapy Prediction and Expansion of Proprietary Genomic Tests’ Utility to Identify Patients Who Will Benefit Most from Specific Treatments
Data demonstrate Research Use Only ImPrint test’s ability to identify patients with high risk early breast cancer who may benefit from PD-1/PD-L1 checkpoint inhibition 04/06/2022 — IRVINE, Calif. & AMSTERDAM […]
Celmatix Announces Achievement of Key Preclinical Milestones in Premature Menopause Prevention Drug Program
Lead AMHR2 agonist compound demonstrates high specific activity in biological assays and desired pharmacokinetic profile in preclinical animal studies 16/05/2022 — NEW YORK — (BUSINESS WIRE) Celmatix Inc. a biotechnology […]
Medicago Announces Publication of Phase 3 COVID-19 Vaccine Study Results in New England Journal of Medicine
Study results were included in the submission to Health Canada leading to Notice of Compliance 05/05/2022 — QUEBEC CITY — (BUSINESS WIRE) Medicago today announced the publication of the results […]
Agendia Appoints Farida Peters-Abbadi as Vice President of Marketing
Strategic hireunderscores commitment to commercial growth across genomic assay portfolio 04/04/2022 — IRVINE, Calif. & AMSTERDAM, Netherlands — (BUSINESS WIRE) Agendia, Inc., a commercial stage company focused on enabling optimized […]
Personalis to Present Data Demonstrating Breadth of NeXT Platform for Oncology at AACR Annual Meeting 2022
23/03/2022 — MENLO PARK, Calif. — (BUSINESS WIRE) Personalis, Inc. (Nasdaq: PSNL), a leader in advanced genomics for precision oncology, announced it is presenting new data in scientific posters at […]